After a sharp plunge, Epizyme bounces back on some bonny forecasts as shares go on a roller coaster ride
Yesterday I reported that Epizyme shares $EPZM took a dive after the company reported some disappointing data on its DLBCL group in an ongoing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
